Elliott Associates is Buying Advisory Board Co. (NASDAQ:ABCO) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Advisory Board Co. (NASDAQ:ABCO) reported that Elliott Associates, L.p. has picked up 649,898 of common stock as of 2017-03-03.
The acquisition brings the aggregate amount owned by Elliott Associates, L.p. to a total of 649,898 representing a 1.6% stake in the company.
For those not familiar with the company, The Advisory Board Company is a provider of software and solutions to the healthcare and higher education industries. The Company’s healthcare programs address a range of clinical and business issues, including physician alignment and engagement, network management and growth strategy, value-based care and population health, revenue cycle, clinical operations and supply chain. Its higher education programs support colleges and universities in enrollment management; academic programming and student learning; faculty recruitment and retention; student advising and success; alumni affairs and advancement, and college and university operations. The Company offers distinct membership programs, across four areas, which include best practices research and insight, performance technology software, consulting and management services, and data- and tech-enabled services. Its best practices research and insight programs provide the foundation for all of its other programs.
A glance at Advisory Board Co. (NASDAQ:ABCO)’s key stats reveals a current market capitalization of 1.78 Billion based on 40.14 Million shares outstanding and a price at last close of $45.00 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-05-31, Kindick picked up 5,000 at a purchase price of $32.81. This brings their total holding to 22,662 as of the date of the filing.
On the sell side, the most recent transaction saw Miller unload 750 shares at a sale price of $45.16. This brings their total holding to 17,487.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Advisory Board Co. (NASDAQ:ABCO) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Puri Nathu R Picked Up Cenveo Inc. (NYSE:CVO) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Cenveo Inc. (NYSE:CVO) reported that Puri Nathu R has picked up 550,000 of common stock as of 2017-03-03.
The acquisition brings the aggregate amount owned by Puri Nathu R to a total of 550,000 representing a 6.4327485% stake in the company.
For those not familiar with the company, Cenveo, Inc. is a diversified manufacturing company focused on print-related products. The Company’s portfolio of products includes envelope converting, commercial printing and label manufacturing. The Company operates through three segments: Envelope, Print and Label. The Company’s Envelope segment offers direct mail products used for customer solicitations and transactional envelopes used for billing and remittance by end users, including financial institutions, insurance companies and telecommunications companies. The Company’s Print segment provides a range of print offerings to its customers, including electronic prepress, digital asset archiving, direct-to-plate technology, color printing on Web and sheet-fed presses, digital printing and content management. The Company’s Label segment specializes in the design, manufacturing and printing of labels, such as custom labels, overnight packaging labels and pressure-sensitive prescription labels.
A glance at Cenveo Inc. (NYSE:CVO)’s key stats reveals a current market capitalization of 44.10 Million based on 8.55 Million shares outstanding and a price at last close of $5.31 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-12-01, Burton picked up 14,050 at a purchase price of $7.20. This brings their total holding to 325,846 as of the date of the filing.
On the sell side, the most recent transaction saw Haji unload 1,582 shares at a sale price of $7.76. This brings their total holding to 87,620.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Cenveo Inc. (NYSE:CVO) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Guess Who Picked Up Quantum Corp (NYSE:QTM) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Quantum Corp (NYSE:QTM) reported that Viex Capital Advisors, Llc. has picked up 7,407,865 of common stock as of 2017-03-03.
The acquisition brings the aggregate amount owned by Viex Capital Advisors, Llc. to a total of 7,407,865 representing a 2.7% stake in the company.
For those not familiar with the company, Quantum Corporation focuses on scale-out storage, archive and data protection, providing solutions for capturing, sharing, managing and preserving digital assets over the entire data lifecycle. The Company’s end-to-end tiered storage solutions enable users to maximize the value of their data by making it accessible whenever and wherever needed, retaining it indefinitely and reducing total cost and complexity. It works with a network of distributors, value-added resellers (VARs), direct marketing resellers (DMRs), original equipment manufacturers (OEMs) and other suppliers to meet customers’ evolving needs. Its scale-out storage portfolio includes StorNext software, appliances and full systems called StorNext Pro Solutions, as well as Xcellis workflow storage, QXS disk storage, Lattus extended online storage and Q-Cloud Archive and Vault services. Its StorNext offerings enable customers to manage large unstructured data sets in an information workflow.
A glance at Quantum Corp (NYSE:QTM)’s key stats reveals a current market capitalization of 258.63 Million based on 271.32 Million shares outstanding and a price at last close of $0.947 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2015-11-20, Stedman picked up 621 at a purchase price of $0.88. This brings their total holding to 406,590 as of the date of the filing.
On the sell side, the most recent transaction saw Smith unload 1,416,577 shares at a sale price of $0.91. This brings their total holding to 1,500,174.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Quantum Corp (NYSE:QTM) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Here’s Who Just Picked Up Owens & Minor Inc. (NYSE:OMI) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Owens & Minor Inc. (NYSE:OMI) reported that Vanguard Group Inc. has picked up 6,488,060 of common stock as of 2017-03-03.
The acquisition brings the aggregate amount owned by Vanguard Group Inc. to a total of 6,488,060 representing a 10.54% stake in the company.
For those not familiar with the company, Owens & Minor, Inc. is a global healthcare services company. The Company provides supply chain assistance to the providers of healthcare services and the manufacturers of healthcare products, supplies and devices in the United States and Europe. The Company operates in two segments: Domestic and International. The Domestic segment includes all functions relating to its role as a medical supply logistics company providing distribution; kitting, including Medical Action Industries Inc., and logistics services to healthcare providers and manufacturers in the United States. The International segment consists of Movianto Group and ArcRoyal. The Company serves customers with a service portfolio that covers procurement, inventory management, delivery and sourcing for the healthcare market. With fully developed networks in the United States and Europe, it serves hospitals, integrated healthcare systems, group purchasing organizations, the United States federal government and pharmaceuticals.
A glance at Owens & Minor Inc. (NYSE:OMI)’s key stats reveals a current market capitalization of 2.24 Billion based on 61.04 Million shares outstanding and a price at last close of $36.50 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2015-08-26, Simmons picked up 2,200 at a purchase price of $32.75. This brings their total holding to 9,422 as of the date of the filing.
On the sell side, the most recent transaction saw Colpo unload 8,802 shares at a sale price of $36.04. This brings their total holding to 38,705.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Owens & Minor Inc. (NYSE:OMI) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Guess Who Picked Corbus Pharmaceuticals (NASDAQ:CRBP) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP) reported that Stern Adam K has picked up 2,427,250 of common stock as of 2017-03-02.
The acquisition brings the aggregate amount owned by Stern Adam K to a total of 2,427,250 representing a 4.9% stake in the company.
For those not familiar with the company, Corbus Pharmaceuticals Holdings, Inc. is a clinical-stage pharmaceutical company. The Company is focused on the development and commercialization of therapeutics to treat rare or uncommon chronic and serious inflammatory and fibrotic diseases. The Company’s segment is developing and commercializing therapeutics to treat rare life-threatening inflammatory fibrotic diseases. Its product, Resunab, is a synthetic oral endocannabinoid-mimetic drug that is designed to resolve chronic inflammation and halt fibrotic processes without causing immunosuppression. Resunab is being evaluated in approximately three separate Phase II studies for the treatment of cystic fibrosis, systemic sclerosis and skin-predominant dermatomyositis. The United States Food and Drug Administration has granted Resunab Orphan Drug Designation, as well as Fast Track Status, for both cystic fibrosis and systemic sclerosis. Resunab is in Phase II clinical stage for the treatment of Systemic Lupus Erythematosus.
A glance at Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP)’s key stats reveals a current market capitalization of 461.19 Million based on 44.44 Million shares outstanding and a price at last close of $9.76 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-11-22, Cohen picked up 1,340 at a purchase price of $7.64. This brings their total holding to 4,204,562 as of the date of the filing.
On the sell side, the most recent transaction saw Burstein unload 200,000 shares at a sale price of $3.04. This brings their total holding to 3,594,846.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Kalvista Pharmaceuticals Inc. (NASDAQ:KALV) is Attracting Money
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Kalvista Pharmaceuticals Inc. (NASDAQ:KALV) reported that Svlsf Iv, Llc. has picked up 2,579,490 of common stock as of 2017-03-02.
The acquisition brings the aggregate amount owned by Svlsf Iv, Llc. to a total of 2,579,490 representing a 26.6% stake in the company.
For those not familiar with the company, KalVista Pharmaceuticals, Inc., formerly Carbylan Therapeutics, Inc., is a clinical-stage pharmaceutical company. The Company is focused on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The Company has developed a portfolio of small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME). The Company is developing a plasma kallikrein inhibitor, which is administered directly into the eye. The Company is engaged in advancing several product candidates developed from its portfolio into early clinical trials. The Company is progressing additional oral candidates towards regulatory preclinical studies. The Company’s HAE product candidate, KVD818, is an inhibitor of plasma kallikrein. The Company has initiated clinical testing of KVD818 in a Phase I clinical trial. It has completed an open-label single ascending dose Phase I trial in DME patients with KVD001.
A glance at Kalvista Pharmaceuticals Inc. (NASDAQ:KALV)’s key stats reveals a current market capitalization of 72.55 Million based on 9.93 Million shares outstanding and a price at last close of $7.39 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2015-04-14, Cha picked up 7,364 at a purchase price of $5.00. This brings their total holding to 4,204,562 as of the date of the filing.
On the sell side, the most recent transaction saw Renzi unload 10,000 shares at a sale price of $3.70. This brings their total holding to 0.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Kalvista Pharmaceuticals Inc. (NASDAQ:KALV) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Hma Acquisition, Inc. is Buying Stage Stores Inc. (NYSE:SSI) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Stage Stores Inc. (NYSE:SSI) reported that Hma Acquisition, Inc. has picked up 1,366,415 of common stock as of 2017-03-02.
The acquisition brings the aggregate amount owned by Hma Acquisition, Inc. to a total of 1,366,415 representing a 5.03% stake in the company.
For those not familiar with the company, Stage Stores, Inc. operates specialty department stores mainly in small and mid-sized towns and communities. The Company’s department stores offer a range of brand name and private label apparel, accessories, cosmetics, footwear and home goods. The Company operates approximately 830 specialty department stores in over 40 states under the BEALLS, GOODY’S, PALAIS ROYAL, PEEBLES and STAGE nameplates and a direct-to-consumer business. The Company’s direct-to-consumer business consists of its e-commerce Website and Send program. The Company’s e-commerce Website includes a range of merchandise categories found in its stores, as well as other product offerings. The Company’s in-store Send program allows customers to have merchandise shipped directly to their homes if the preferred size or color is not available in their local store. The Company’s private label portfolio brands are developed and sourced through agreements with third-party vendors.
A glance at Stage Stores Inc. (NYSE:SSI)’s key stats reveals a current market capitalization of 57.88 Million based on 27.17 Million shares outstanding and a price at last close of $2.13 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-06-20, Lundy picked up 4,000 at a purchase price of $5.18. This brings their total holding to 89,807 as of the date of the filing.
On the sell side, the most recent transaction saw Shein unload 5,000 shares at a sale price of $22.42. This brings their total holding to 42,531.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Stage Stores Inc. (NYSE:SSI) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Sacks Bradley J. Picked Up Uluru Inc. (OTCMKTS:ULUR) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Uluru Inc. (OTCMKTS:ULUR) reported that Sacks Bradley J. has picked up 552,960 of common stock as of 2017-03-02.
The acquisition brings the aggregate amount owned by Sacks Bradley J. to a total of 552,960 representing a 0.9% stake in the company.
For those not familiar with the company, ULURU Inc. is a specialty pharmaceutical company focused on developing and commercializing a range of wound care and muco-adhesive film products based on its Nanoflex and OraDisc technologies for patients, healthcare professionals and healthcare payers. The Company operates through the research, development and commercialization of pharmaceutical products segment. Utilizing its technologies, three of its products have been approved for marketing in various global markets. Altrazeal Transforming Powder Dressing is based on its Nanoflex technology, which changes the way healthcare providers approach their treatment of wounds. The product is indicated for both exuding acute wounds, such as donor sites, non-healing surgical wounds, and trauma and for chronic wounds, such as venous leg ulcers, diabetic foot ulcers and pressure ulcers. Aphthasol is a drug approved for the treatment of canker sores. OraDisc is developed as an improved drug delivery system for the treatment of canker sores.
A glance at Uluru Inc. (OTCMKTS:ULUR)’s key stats reveals a current market capitalization of 4.03 million based on 62.97 Million shares outstanding and a price at last close of $0.0711 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-03-29, Wallberg picked up 701,262 at a purchase price of $0.07. This brings their total holding to 825,519 as of the date of the filing.
On the sell side, the most recent transaction saw Oss unload 3,400,000 shares at a sale price of $0.16. This brings their total holding to 8,061,522.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Uluru Inc. (OTCMKTS:ULUR) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.